2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$40.95-$0.86 (-2.06%)
Price as of Jul 13, 2026 7:19 PM EDT- $1.6BMarket Cap
- 17.38%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$40.95-$0.86 (-2.06%)
HROW | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $41.81 | ||
Change | -$0.67 (-1.58%) | ||
Open | $41.96 | ||
High | $42.44 | ||
Low | $41.40 | ||
Previous Close | $42.48 | ||
Volume | 289,307 | ||
30-Day Average Volume | 768,990 | ||
1-Week Change | -6.94% | ||
1-Month Change | 11.08% | ||
1-Year Change | 17.38% | ||
3-Year Change | 134.49% | ||
5-Year Change | 460.46% | ||
Fundamentals | |||
Shares Outstanding | 37.3M | ||
Total Assets | $419.5M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$9.2M | ||
EBIT | $25,000.00 | ||
EBITDA | $480,000.00 | ||
Net Working Capital | $134.9M | ||
EPS | -$0.74 | ||
Enterprise Value/EBITDA | 3,658 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 54 | ||
P/E | -57 | ||
PEG | N/A | ||
Price/Free Cash Flow | -170 | ||
Price/Operating Cash Flow | -173 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 02/08/2013 | ||
Earnings & Revenue